Not exact matches
Based on the findings described in Scientific Reports, the study authors are cautiously optimistic about the therapeutic potential of
mifepristone for patients with vestibular schwannomas, either from NF2 or those arising sporadically.
The US Food and Drug Administration should consider approving the French «abortion pill»
mifepristone (RU486) on the
basis of European data, rather than waiting for clinical trials in the US, according to a panel of experts convened by the US National Academy of Sciences.
In addition, Arizona enacted a provision that requires
mifepristone to be provided in accordance with an outdated FDA protocol rather than a simpler, long - standing evidence -
based protocol that is equally safe and effective with fewer side effects.
Three of these states, Kansas, North Dakota and Oklahoma, also require that
mifepristone be provided in accordance with a long - standing FDA protocol rather than under a simpler evidence -
based protocol that has been proven to be safe and effective.
Until now, the FDA label for Mifeprex, the brand name for
mifepristone, had been
based on studies from the 1990s.
Until today, the regimen outlined on
mifepristone's label was
based on clinical trials from way back in the «90s.